Manolakopoulos S, Akriviadis E, Vlachogiannakos J, Papageorgiou M-V, Kapatais A, Oikonomopoulou M, Vasileiadis TG, Manesis EK, Karatapanis S, Deutsch M, et al. The impact of direct acting antivirals (DAAs) in patients with decompensated liver disease (DLD) due to chronic hepatitis C (CHC). heraclis-a multicenter greek real world study. In: Hepatology. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 838A–839A. Copy at http://www.tinyurl.com/ymbuh7y8